glp 1 pipeline What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care Frontiers | Beyond GLP-1: underexplored

Bie J, Pruszyska-Oszmaek E, Koodziejski P, Leciejewska N, Szczepankiewicz D, Sassek M

Kimuras, americanas, and various arm locks apply rotational stress that can damage the rotator cuff, labrum, and surrounding structures

GLP-1 agonists for alcohol use disorder represent an emerging area of research interest, though these medications remain unlicensed for this indication in the UK

In AD, EGCG interferes with A aggregation, promotes non-toxic oligomers, and reduces tau hyperphosphorylation

Once someone reaches their lowest sustainable weight or their target health improvements, they should continue with the lowest effective dose that maintains their progress